Natco Pharma Share Price
13 Aug, 2026 3:59 PM (IST)
Natco Pharma Performance
- Today's Low
- ₹917
- Today's High
- ₹962
- 52 Week Low
- ₹789
- 52 Week High
- ₹1,227
- Open Price₹920
- Previous Close₹915
- Volume1,277,402
- 50 DMA₹945.70
- 100 DMA₹959.10
- 200 DMA₹957.30
Natco Pharma Chart
Investment Returns
- Over 1 Month -3.29%
- Over 3 Month -19.48%
- Over 6 Month + 13.32%
- Over 1 Year + 7.14%
Smart Investing Starts Here Start SIP with Natco Pharma for Steady Growth!
Natco Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12
- PEG Ratio
- -0.5
- Market Cap Cr
- 17,046
- P/B Ratio
- 1.8
- Average True Range
- 24.6
- EPS
- 79.2
- Dividend Yield
- 0.5
- MACD Signal
- -6.2
- RSI
- 57.16
- MFI
- 53.79
Latest Stock News Updates
The Company will host an Earnings Call with Investors / Analysts on Friday, the 14th August, 2026 at 17:30 PM IST to discuss the Un-audited Financial Results of the Company for the quarter ended 30th June, 2026
- BSE India
- 2 days 9 hours ago
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Further to our earlier intimation dated August 6, 2026, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that a meeting of the Board of Directors of the Company will be held on August 14, 2026 to consider and evaluate proposals for raising funds through issuance of equity shares or other securities, including by way of a public issue, preferential issue, rights issue, private placement(s), qualified institutions placement(s) and/or any combination thereof or any other method as may be permitted in accordance with provisions of applicable laws, subject to market conditions and receipt of regulatory, statutory and other approvals as may be required
- BSE India
- 2 days 9 hours ago
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Un-audited Financial Results for the quarter ended 30th June, 2026 and declare Interim Dividend, if any for the FY 2026-27
- BSE India
- 1 week ago
Natco Pharma Financials
Natco Pharma Technicals
EMA & SMA
- Bearish Moving Average 4
- Bullish Moving Average 12
- 20 Day
- ₹927.50
- 50 Day
- ₹945.70
- 100 Day
- ₹959.10
- 200 Day
- ₹957.30
Resistance and Support
- R3 1,014.90
- R2 988.40
- R1 970.10
- S1 925.30
- S2 898.80
- S3 880.50
Natco Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-14 | Quarterly Results & Interim Dividend | |
| 2026-05-29 | Audited Results | |
| 2026-03-24 | Scheme of Arrangement | Inter alia, to consider among other things, the Scheme of Arrangement for the demerger of Agrochemicals Division on a going concern basis into its WoS i.e., Natco Crop Health Sciences Limited. |
| 2026-02-12 | Quarterly Results & Interim Dividend | |
| 2025-11-14 | Quarterly Results & Interim Dividend |
About Natco Pharma
Natco Pharma Ltd. is leading pharmaceutical company in India, specializing in production of generic medicines, bulk drugs, & specialty pharmaceuticals. Founded in 1981, Natco has established itself as key player in global pharmaceutical industry, with strong focus on oncology, cardiology, & gastroenterology segments. company operates state of the art manufacturing facilities that comply with global regulatory standards, ensuring production of high quality medicines. Natco Pharma is known for its innovation, particularly in development of affordable generic versions of high cost drugs, which has made it preferred partner for healthcare providers worldwide.
NATCO Pharma Limited (NATCO) is pharmaceutical firm that focuses on research & development & is vertically integrated. Its core competencies include creating, producing, & selling complicated pharmaceuticals for specific therapeutic areas. NATCO is now present in three business categories of contract manufacturing business, active pharmaceutical ingredients (APIs), & final dosage formulations (FDF).
- NSE Symbol
- NATCOPHARM
- BSE Symbol
- 524816
- ISIN
- INE987B01026
Similar Stocks to Natco Pharma
Popular Stocks
Natco Pharma FAQs
Natco Pharma share price is ₹951 As on 14 August, 2026 | 03:26
The Market Cap of Natco Pharma is ₹17045.9 Cr As on 14 August, 2026 | 03:26
The P/E ratio of Natco Pharma is 12 As on 14 August, 2026 | 03:26
The PB ratio of Natco Pharma is 1.8 As on 14 August, 2026 | 03:26
The 52 week High & Low of Natco Pharma is ₹1226.8/₹789 respectively As on 14 August, 2026 | 03:26
Evaluate company's performance in pharmaceutical industry & its product pipeline before investing
Key metrics include revenue growth, product approvals, & profit margins.
Open Demat account with 5 Paisa Capital & post doing KYC & active account search for Natco Pharma share, you can then put order as you prefer.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.